Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity

Xuefang Ren1, Kozaburo Akiyoshi, Marjorie R Grafe

  • 1Department of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, OR, USA.

Metabolic Brain Disease
|October 13, 2011
PubMed

Insights

Immune cells targeting central nervous system (CNS) antigens worsen stroke damage. Myelin-reactive T cells exacerbated infarct volume and neurological deficits in mice after ischemic stroke.

Area of Science:

  • Neuroimmunology
  • Stroke research
  • Autoimmunity

Background:

  • Inflammatory responses exacerbate stroke severity.
  • The role of CNS-antigen-specific immune cells in stroke is debated.
  • Blood-brain barrier disruption during stroke allows immune cell infiltration.

Purpose of the Study:

  • To investigate the impact of myelin-reactive T cells on ischemic stroke.
  • To determine if CNS autoimmunity exacerbates stroke-induced brain damage.

Main Methods:

  • Transfer of myelin oligodendrocyte glycoprotein (MOG)-reactive splenocytes into severe combined immunodeficient (SCID) mice.
  • Induction of focal cerebral ischemia via middle cerebral artery occlusion (MCAO) in recipient mice.
  • Assessment of infarct volume and neurological deficits 96 hours post-reperfusion.

Main Results:

  • MOG-reactive splenocytes migrated to the infarct hemisphere in MCAO mice.
  • Adoptive transfer of MOG-reactive cells significantly increased infarct volume.
  • Mice receiving MOG-reactive cells exhibited worsened neurological deficits compared to controls.

Conclusions:

  • CNS autoimmunity can be detrimental to brain cells during ischemic stroke.
  • Myelin-reactive immune cells exacerbate ischemic brain injury and neurological deficits.
  • These findings highlight a potential mechanism for autoimmune exacerbation of stroke damage.

Related Concept Videos